Literature DB >> 31951250

Cordycepin protects renal ischemia/reperfusion injury through regulating inflammation, apoptosis, and oxidative stress.

Feng Han1, Meng Dou1, Yuxiang Wang1, Cuixiang Xu1,2, Yang Li1,3, XiaoMing Ding1,3, WuJun Xue1,3, Jin Zheng1,3, Puxun Tian1,3, Chenguang Ding1,3.   

Abstract

Cordycepin (3'-deoxyadenosine) is a naturally occurring adenosine analog and one of the bioactive constituents isolated from Cordyceps sinensis, species of the fungal genus Cordyceps. It has traditionally been a prized Chinese folk medicine for the human well-being. However, the actions of cordycepin against renal ischemia/reperfusion injury (I/R) are still unknown. In the present study, rats were subject to I/R and cordycepin was intragastrically administered for seven consecutive days before surgery to investigate the effects and mechanisms of cordycepin against renal I/R injury. The test results of kidney and peripheral blood samples of experimental animals showed that cordycepin significantly decreased serum blood urea nitrogen and creatinine levels and markedly attenuated cell injury. Mechanistic studies showed that cordycepin significantly regulated inflammation, apoptosis, and oxidative stress. These data provide new insights for investigating the natural product with the nephroprotective effect against I/R, which should be developed as a new therapeutic agent for the treatment of I/R in the future.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  apoptosis; cordycepin; inflammation; oxidative stress; renal ischemia/reperfusion injury

Year:  2020        PMID: 31951250     DOI: 10.1093/abbs/gmz145

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  7 in total

1.  Network Pharmacology-Based Exploration of the Therapeutic Mechanisms of Cordyceps cicadae in Renal Ischemia/Reperfusion.

Authors:  Jiajun Dong; Mingyang Cao; Hui Yu; Yang Dong; Conghui Han
Journal:  Ann Transplant       Date:  2022-09-30       Impact factor: 1.479

2.  The effect of Bailing capsules combined with losartan to treat diabetic glomerulosclerosis and the combination's effect on blood and urine biochemistry.

Authors:  Wenhui Yu; Shuzhong Duan; Zaixue Yu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Tetramethylpyrazine alleviates acute kidney injury by inhibiting NLRP3/HIF‑1α and apoptosis.

Authors:  Wangnan Sun; Aiqun Li; Zhiqiang Wang; Xuhong Sun; Menghua Dong; Fu Qi; Lin Wang; Yueheng Zhang; Pengchao Du
Journal:  Mol Med Rep       Date:  2020-07-28       Impact factor: 2.952

4.  Identification and functional analysis of bacteria in sclerotia of Cordyceps militaris.

Authors:  Li Luo; Jiaxi Zhou; Zhongshun Xu; Jingqiang Guan; Yingming Gao; Xiao Zou
Journal:  PeerJ       Date:  2021-11-25       Impact factor: 2.984

Review 5.  Recent Advances in Traditional Chinese Medicine for Treatment of Podocyte Injury.

Authors:  Tianwen Yao; Wenxiang Su; Shisheng Han; Yan Lu; Yanqiu Xu; Min Chen; Yi Wang
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

Review 6.  Potential Therapeutic Strategies for Renal Fibrosis: Cordyceps and Related Products.

Authors:  Wei Tan; Yunyan Wang; Hongmei Dai; Junhui Deng; Zhifen Wu; Lirong Lin; Jurong Yang
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

7.  Cordycepin Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats via Modulation of AMPK and AKT Activation.

Authors:  Abdulmohsin J Alamoudi; Sami A Alessi; Waleed Y Rizg; Abdulmajeed M Jali; Awaji Y Safhi; Fahad Y Sabei; Sameer Alshehri; Khaled M Hosny; Ashraf B Abdel-Naim
Journal:  Pharmaceutics       Date:  2022-08-08       Impact factor: 6.525

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.